Pay with

USD

Supports Visa, Mastercard, SEPA & more

Flexible trading, zero fees

Use your crypto for payments worldwide

Basic

Trade crypto freely

Magnify your profit with leverage

Convert & Auto-Invest

Trade any size with no fees and no slippage

Get exposure to leveraged positions simply

Pre-Market Trading

Trade new tokens before listing

Advanced

Trade on-chain with Gate Wallet

Smart access to new on-chain tokens

Smart strategies with automated trading

Follow expert trading strategies

CrossEx Trading

One margin balance, shared across platforms

Access hundreds of perpetual contracts

One platform for global traditional assets

Trade European-style vanilla options

Unified Account

Maximize your capital efficiency

Introduction to Futures Trading

Learn the basics of futures trading

Join events to earn rewards

Use virtual funds to practice risk-free trading

Stock CFD Derivatives

Access real US stocks and ETFs

Trade quality Hong Kong-listed stocks

Real Korean stocks and top assets

High leverage, 24/7 trading

Tokenized Stocks

Backed by real stock assets

Unlock full access to global stock IPOs

Mint GUSD for Treasury RWA yields

Stocks Activities

Trade Popular Stocks and Unlock Generous Airdrops

Launch

Collect candies to earn airdrops

Quick staking, earn potential new tokens

Hold GT and get massive airdrops for free

Unlock full access to global stock IPOs

Trade on-chain assets and earn airdrops

Earn futures points and claim airdrop rewards

Investment

Earn interest with idle tokens

Auto-invest on a regular basis

Dual Investment

Profit from market volatility

Earn rewards with flexible staking

Pledge one crypto to borrow another

One-stop lending hub

Limited-Time 4% APR on USDT

Take control of your financial future

Top-tier quant strategies

Stake cryptos to earn in PoS products

No-liquidation leverage

Mint and redeem anytime, no redemption fees

Post, share, and explore crypto trends

Live crypto market analysis

Chat with crypto traders

What is happening in crypto

More

Promotions

Activity Center

Participate in activities to earn rewards

Invite friends to earn referral rewards

Affiliate Program

Earn exclusive commission rewards

Grow influence and earn airdrops

Real-time platform updates

Crypto industry articles

Huge fee discounts

Asset Management

One‑stop asset management solution

Enterprise digital asset solutions

Developers (API)

Connects to the Gate application ecosystem

OTC Bank Transfer

Deposit and withdraw fiat

Generous API rebate mechanisms

AI

Your all-in-one conversational AI partner

Use Gate AI directly in your social App

Gate Blue Lobster, ready to go

Gate for AI Agent

AI infrastructure, Gate MCP, Skills, and CLI

Gate Skills Hub

From office tasks to trading, the all-in-one skill hub makes AI even more useful.

Others

Find FAQs and help guides

Learn about crypto investing

Grow with the champions

Proof of Reserves

Gate promises 100% proof of reserves

Keep your assets secure

IngeniaTherapeutics Opens IPO at 12,000-14,500 KRW, Targets August 18 Listing

2026-07-25 22:13:34

Samsung Securities-4.38%

According to the financial investment industry, IngeniaTherapeutics, an antibody drug development biotech company, will open its public offering to retail investors on July 30-31 at a price range of 12,000-14,500 Korean won per share. The offering is managed by Samsung Securities. Based on this pricing, the expected fundraising amount is 60-72.5 billion won, with an anticipated market capitalization of 593.3-716.9 billion won. The company, founded in Boston in 2018, develops antibodies targeting damaged microvessels and retinal diseases. Its lead candidate, IGT-427, was licensed to UK biotech firm iBio for over 1 trillion won in 2022; iBio was subsequently acquired by U.S. pharmaceutical company MSD. The company targets a Kosdaq listing on August 18.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.

Related News

Medical Display Maker D&I Valued at Up to 500B Won, 3x Jump Since 2024 Acquisition

Ingenium Therapeutics Launches IPO on July 30-31; Neoview Re-lists on KOSDAQ

HLG Genomics Plunges 31% on Debut Day; 82% of Recent IPOs Trading Below Issue Price

Macquarie Launches 627.6 Billion Won Tender Offer for KOSDAQ-Listed Gavia by September 17

Eugene Investment Raises Samsung E&A Target Price to 77,000 Won, Up 13.2%, Citing Path to 1 Trillion Won Annual Operating Profit

In-Depth Analysis

Ingenia Therapeutics IPO Subscription Opens July 30 on KOSDAQ

Lucas Bennett07-25 00:20

HL Genomics Stocks Fall 31% on Debut as Korean IPO Market Struggles

Lucas Bennett07-24 20:56

Samsung E&A Target Price Raised 3% to 69,000 Won by iM Securities

Lucas Bennett07-23 23:03

Comment

0/400

No comments